Insiders · Profile

Ives Jeffrey L.

Director at Acumen Pharmaceuticals · Director at Tvardi Therapeutics. Filing since 1 Jul 2019. CIK 0001614096

Company
Date
Role
Action
Shares
Amount
Of holding
17 Aug 2023
Director
Sold on a plan
41,949
$272.33K
100%
15 Jul 2022
Director
Sold, plan not stated
3,600
$32.58K
18.9%
12 Nov 2021
Director
Sold, plan not stated
8,180
$131.21K
53.2%
7 Jun 2021
Director
Sold, plan not stated
2,520
$32.89K
14.1%
1 Jun 2020
Director
Sold, plan not stated
1,000
$16.00K
14.3%
12 May 2020
Director
Sold, plan not stated
2,500
$40.00K
29.4%
21 Apr 2020
Director
Sold, plan not stated
2,500
$40.00K
29.4%
4 Mar 2020
Director
Sold, plan not stated
2,500
$40.00K
29.4%
3 Feb 2020
Director
Sold, plan not stated
2,500
$40.58K
29.4%
2 Jan 2020
Director
Sold, plan not stated
2,500
$40.33K
29.4%
2 Dec 2019
Director
Sold, plan not stated
2,500
$64.58K
29.4%
1 Nov 2019
Director
Sold, plan not stated
2,500
$51.70K
29.4%
1 Oct 2019
Director
Sold, plan not stated
2,500
$45.53K
29.4%
3 Sep 2019
Director
Sold, plan not stated
2,500
$58.28K
29.4%
1 Aug 2019
Director
Sold, plan not stated
2,500
$58.10K
29.4%
1 Jul 2019
Director
Sold, plan not stated
2,500
$54.38K
29.4%
16 decisions on file.